Saara Laukkanen

Tampere, 33520, Finland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Arginine Methyltransferase PRMT7 Deregulates Expression of RUNX1 Target Genes in T-Cell Acute Lymphoblastic Leukemia.

Arginine Methyltransferase PRMT7 Deregulates Expression of RUNX1 Target Genes in T-Cell Acute Lymphoblastic Leukemia.

Journal: Cancers
Published: March 18, 2022

In vivo interrogation of regulatory genomes reveals extensive quasi-insufficiency in cancer evolution.

In vivo interrogation of regulatory genomes reveals extensive quasi-insufficiency in cancer evolution.

Journal: Cell genomics
Published: March 10, 2022

Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia.

Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia.

Journal: Blood
Published: December 08, 2021

Expression of BCL6 in paediatric B-cell acute lymphoblastic leukaemia and association with prognosis.

Expression of BCL6 in paediatric B-cell acute lymphoblastic leukaemia and association with prognosis.

Journal: Pathology
Published: November 03, 2020

SIX6 is a TAL1-regulated transcription factor in T-ALL and associated with inferior outcome.

SIX6 is a TAL1-regulated transcription factor in T-ALL and associated with inferior outcome.

Journal: Leukemia & lymphoma
Published: August 25, 2020

Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1-positive pediatric leukemia identifies drug-targetable transcription factor activities.

Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1-positive pediatric leukemia identifies drug-targetable transcription factor activities.

Journal: Genome medicine
Published: May 07, 2020

Clinicopathological features and prognostic value of SOX11 in childhood acute lymphoblastic leukemia.

Clinicopathological features and prognostic value of SOX11 in childhood acute lymphoblastic leukemia.

Journal: Scientific reports
Published: June 28, 2019

In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL.

In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL.

Journal: Blood cancer journal
Published: September 09, 2017

Overexpression of PTP4A3 in ETV6-RUNX1 acute lymphoblastic leukemia.

Overexpression of PTP4A3 in ETV6-RUNX1 acute lymphoblastic leukemia.

Journal: Leukemia research
Published: August 03, 2016

Transcription-coupled genetic instability marks acute lymphoblastic leukemia structural variation hotspots.

Transcription-coupled genetic instability marks acute lymphoblastic leukemia structural variation hotspots.

Journal: eLife
Published: November 16, 2015

Genome-wide repression of eRNA and target gene loci by the ETV6-RUNX1 fusion in acute leukemia.

Genome-wide repression of eRNA and target gene loci by the ETV6-RUNX1 fusion in acute leukemia.

Journal: Genome research
Published: April 26, 2015
Showing 1-11 of 11

Last Updated: 09/26/2026